Phosphoinositide 3-Kinase (PI3K) Inhibitors Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: PB84C7983158EN
Market Monitor Global

Abstracts

PI3K inhibitors work by inhibiting PI3K enzymes, which helps in signaling the pathway for cellular functions such as growth control, metabolism, and translation initiation.

This report contains market size and forecasts of Phosphoinositide 3-Kinase (PI3K) Inhibitors in Global, including the following market information:

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Phosphoinositide 3-Kinase (PI3K) Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

CLL - Chronic Iymphocytic Ieukemia Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Phosphoinositide 3-Kinase (PI3K) Inhibitors include Bayer AG, Gilead Sciences Inc., Novartis AG, TG Therapeutics Inc. and Verastem Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Phosphoinositide 3-Kinase (PI3K) Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Segment Percentages, by Type, 2021 (%)

• CLL - Chronic Iymphocytic Ieukemia
• FL - Follicular Iymphoma
• Other Indications

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Segment Percentages, by Application, 2021 (%)

• hospital
• Research Institutes and Research Institutions
• Clinic
• Other

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Phosphoinositide 3-Kinase (PI3K) Inhibitors revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Phosphoinositide 3-Kinase (PI3K) Inhibitors revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer AG
• Gilead Sciences Inc.
• Novartis AG
• TG Therapeutics Inc.
• Verastem Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS OVERALL MARKET SIZE

2.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size: 2021 VS 2028
2.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players in Global Market
3.2 Top Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Companies Ranked by Revenue
3.3 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 Phosphoinositide 3-Kinase (PI3K) Inhibitors Companies in Global Market, by Revenue in 2021
3.5 Global Companies Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Players in Global Market
  3.6.1 List of Global Tier 1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Companies
  3.6.2 List of Global Tier 2 and Tier 3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Markets, 2021 & 2028
  4.1.2 CLL - Chronic Iymphocytic Ieukemia
  4.1.3 FL - Follicular Iymphoma
  4.1.4 Other Indications
4.2 By Type - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue & Forecasts
  4.2.1 By Type - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, 2017-2022
  4.2.2 By Type - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, 2023-2028
  4.2.3 By Type - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2021 & 2028
  5.1.2 hospital
  5.1.3 Research Institutes and Research Institutions
  5.1.4 Clinic
  5.1.5 Other
5.2 By Application - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue & Forecasts
  5.2.1 By Application - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, 2017-2022
  5.2.2 By Application - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, 2023-2028
  5.2.3 By Application - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue & Forecasts
  6.2.1 By Region - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, 2017-2022
  6.2.2 By Region - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, 2023-2028
  6.2.3 By Region - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, 2017-2028
  6.3.2 US Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.3.3 Canada Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.3.4 Mexico Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, 2017-2028
  6.4.2 Germany Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.4.3 France Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.4.4 U.K. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.4.5 Italy Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.4.6 Russia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.4.7 Nordic Countries Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.4.8 Benelux Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, 2017-2028
  6.5.2 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.5.3 Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.5.4 South Korea Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.5.5 Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.5.6 India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, 2017-2028
  6.6.2 Brazil Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.6.3 Argentina Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, 2017-2028
  6.7.2 Turkey Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.7.3 Israel Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.7.4 Saudi Arabia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028
  6.7.5 UAE Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer AG
  7.1.1 Bayer AG Corporate Summary
  7.1.2 Bayer AG Business Overview
  7.1.3 Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Major Product Offerings
  7.1.4 Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in Global Market (2017-2022)
  7.1.5 Bayer AG Key News
7.2 Gilead Sciences Inc.
  7.2.1 Gilead Sciences Inc. Corporate Summary
  7.2.2 Gilead Sciences Inc. Business Overview
  7.2.3 Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Major Product Offerings
  7.2.4 Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in Global Market (2017-2022)
  7.2.5 Gilead Sciences Inc. Key News
7.3 Novartis AG
  7.3.1 Novartis AG Corporate Summary
  7.3.2 Novartis AG Business Overview
  7.3.3 Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Major Product Offerings
  7.3.4 Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in Global Market (2017-2022)
  7.3.5 Novartis AG Key News
7.4 TG Therapeutics Inc.
  7.4.1 TG Therapeutics Inc. Corporate Summary
  7.4.2 TG Therapeutics Inc. Business Overview
  7.4.3 TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Major Product Offerings
  7.4.4 TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in Global Market (2017-2022)
  7.4.5 TG Therapeutics Inc. Key News
7.5 Verastem Inc.
  7.5.1 Verastem Inc. Corporate Summary
  7.5.2 Verastem Inc. Business Overview
  7.5.3 Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Major Product Offerings
  7.5.4 Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in Global Market (2017-2022)
  7.5.5 Verastem Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Opportunities & Trends in Global Market
Table 2. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Drivers in Global Market
Table 3. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Restraints in Global Market
Table 4. Key Players of Phosphoinositide 3-Kinase (PI3K) Inhibitors in Global Market
Table 5. Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Share by Companies, 2017-2022
Table 8. Global Companies Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Type
Table 9. List of Global Tier 1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 30. Bayer AG Corporate Summary
Table 31. Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offerings
Table 32. Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (US$, Mn), (2017-2022)
Table 33. Gilead Sciences Inc. Corporate Summary
Table 34. Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offerings
Table 35. Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (US$, Mn), (2017-2022)
Table 36. Novartis AG Corporate Summary
Table 37. Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offerings
Table 38. Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (US$, Mn), (2017-2022)
Table 39. TG Therapeutics Inc. Corporate Summary
Table 40. TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offerings
Table 41. TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (US$, Mn), (2017-2022)
Table 42. Verastem Inc. Corporate Summary
Table 43. Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offerings
Table 44. Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Phosphoinositide 3-Kinase (PI3K) Inhibitors Segment by Type in 2021
Figure 2. Phosphoinositide 3-Kinase (PI3K) Inhibitors Segment by Application in 2021
Figure 3. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in 2021
Figure 8. By Type - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share, 2017-2028
Figure 9. By Application - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share, 2017-2028
Figure 10. By Region - Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Country - North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share, 2017-2028
Figure 12. US Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share, 2017-2028
Figure 16. Germany Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 17. France Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share, 2017-2028
Figure 24. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. India Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share, 2017-2028
Figure 30. Brazil Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share, 2017-2028
Figure 33. Turkey Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)